Integra LifeSciences Holdings Corp (IART)

Common Shares
Sell: $10.34|Buy: $11.75|Change: 0.20 (1.82%)

Company profile

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Address

1100 Campus Road
Princeton
NJ
USA
08540


Telephone

+1 609 275-0500


Sector 

Healthcare


Previous key dates

NameKey Date
Integra Lifesciences Holdings Corp Fourth Quarter Earnings Conference Call for 20252026-02-26T08:30:00
Integra Lifesciences Holdings Corp Fourth Quarter Earnings Results for 20252026-02-26T00:00:00
Integra Lifesciences Holdings Corp Annual Report for 20252026-02-25T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-14T14:15:00
Citi 2025 Global Healthcare Conference2025-12-03T10:30:00
Integra Lifesciences Holdings Corp Third Quarter Earnings Conference Call for 20252025-10-30T08:30:00
Integra Lifesciences Holdings Corp Third Quarter Earnings Result for 20252025-10-30T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-10T08:30:00
Wells Fargo 2025 Healthcare Conference2025-09-03T12:45:00
Integra Lifesciences Holdings Corp Second Quarter Earnings Conference Call for 20252025-07-31T08:30:00
Integra Lifesciences Holdings Corp Second Quarter Earnings Result for 20252025-07-31T00:00:00
Integra Lifesciences Holdings Corp Annual General Meeting for 20252025-05-09T09:00:00
Integra Lifesciences Holdings Corp First Quarter Earnings Conference Call for 20252025-05-05T08:30:00
Integra Lifesciences Holdings Corp First Quarter Earnings Result for 20252025-05-05T00:00:00
35th Annual Oppenheimer Healthcare MedTech & Services Conference2025-03-17T10:00:00
Integra Lifesciences Holdings Corp Fourth Quarter Earnings Conference Call for 20242025-02-25T08:30:00
Integra Lifesciences Holdings Corp Fourth Quarter Earnings Result for 20242025-02-25T00:00:00
Integra Lifesciences Holdings Corp Annual Report for 20242025-02-25T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.